Atalante is a self-balanced, lower-body exoskeleton that emulates the way humans walk. The company began clinical trials for the exoskeleton in 2017. It was CE marked in 2019.

Robotic exoskeleton developer Wandercraft has raised $17.8 million in a Series B funding round, according to a ZDNet report. Funds from the round are slated to support certifications and regulatory clearances necessary to bring the exoskeleton to market, according to the report. The Paris-based company claims that its exoskeleton is the 1st to have managed…